Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SLC7A8 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA542455
Description
Peptide sequence: PRAIFISIPL VTFVYVFANV AYVTAMSPQE LLASNAVAVT FGEKLLGVMA Sequence homology: Cow: 100%; Dog: 93%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 100%.
SLC7A8 is sodium-independent, high-affinity transport of large neutral amino acids. It has higher affinity for L-phenylalanine than LAT1 but lower affinity for glutamine and serine. L-alanine is transported at physiological concentrations. SLC7A8 also plays a role in basolateral (re)absorption of neutral amino acids.
Specifications
SLC7A8 | |
Polyclonal | |
Unconjugated | |
SLC7A8 | |
4F2-LC5; 4F2LC-5; AA408822; cationic amino acid transporter y+ system; glycoprotein-associated amino acid transporter LAT2; hLAT2; integral membrane protein E16H; Large neutral amino acids transporter small subunit 2; LAT2; Lat4; LPI-PC1; L-type amino acid transporter 2; mLAT2; Slc7a8; solute carrier family 7 (amino acid transporter light chain, L system), member 8; solute carrier family 7 (amino acid transporter, L-type), member 8; solute carrier family 7 (cationic amino acid transporter, y+ system), member 8; solute carrier family 7 member 8; solute carrier family 8 (cationic amino acid transporter, y+ system), member 7 | |
Rabbit | |
Protein A | |
RUO | |
23428 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
Q9UHI5 | |
SLC7A8 | |
Synthetic peptide directed towards the middle region of human SLC7A8. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction